Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles
Bioavailability of Oral Hydrocortisone Corrected for Binding Proteins and Measured by LC-MS/MS Using Serum Cortisol and Salivary Cortisone
Crude Edible Fig ( Ficus carica) Leaf Extract Prevents Diethylstilbestrol (DES)-Induced DNA Strand Breaks in Single-Cell Gel Electrophoresis (SCGE)/Comet Assay: Literature Review and Pilot Study

View More »

Google Scholar citation report
Citations : 4890

Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report

Journal of Bioequivalence & Bioavailability
Journal of Bioequivalence & Bioavailability peer review process verified at publons
Journal of Bioequivalence & Bioavailability
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability
Open Access Journals
View More

Nilanjan Saha

Nilanjan Saha

Consultant - R&D and Medico-Marketing to Pharma and Life Sciences Industry, India

Biography
Nilanjan Saha is a Consultant - R&D and Medico-Marketing to Pharma and Life Sciences Industry. He has exceptional know how on New product evaluations, positioning in Therapy and ethical marketing. Active proponent of Antibiotic Stewardship. In the past, Volunteer studies with generic and NCEs; Phase I to III Clinical trials with anti-cancer and anti-malarial NCEs. Clinical Development strategies for new Pharmaceutical products. He has completed the development of a new anti-malarial combination. Organised pivotal multi-country clinical trial in 3 Asian and 6 African countries. Synriam, the new combination is now approved in 12 malaria endemic countries, including India. Internationally, Synriam has been launched in several countries where presented data as key note speaker.
Research Interest
Clinical Research, New Pharmaceutical Product Evaluation and Development, Clinical Pharmacology, Therapeutics